AAAAAA

   
Results: 1-9 |
Results: 9
ANTITHROMBOTIC EFFICACY OF RPR208566 A FACTOR XA INHIBITOR IN A RAT MODEL OF CAROTID-ARTERY THROMBOSIS
Authors: HERAN C MORGAN S KASIEWSKI C BOSTWICK J BENTLEY R KOO E KLEIN S CHU V BROWN K COLUSSI D CZEKAJ M PERRONE M LEADLEY R
Citation: C. Heran et al., ANTITHROMBOTIC EFFICACY OF RPR208566 A FACTOR XA INHIBITOR IN A RAT MODEL OF CAROTID-ARTERY THROMBOSIS, The FASEB journal, 12(5), 1998, pp. 4153-4153
IDENTIFICATION AND INITIAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL CLASS OF NONPEPTIDE INHIBITORS OF BLOOD-COAGULATION FACTOR XA
Authors: KLEIN SI CZEKAJ M GARDNER CJ GUERTIN KR CHENEY DL SPADA AP BOLTON SA BROWN K COLUSSI D HERAN CL MORGAN SR LEADLEY RJ DUNWIDDIE CT PERRONE MH CHU V
Citation: Si. Klein et al., IDENTIFICATION AND INITIAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL CLASS OF NONPEPTIDE INHIBITORS OF BLOOD-COAGULATION FACTOR XA, Journal of medicinal chemistry, 41(4), 1998, pp. 437-450
DESIGN OF A NEW CLASS OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS
Authors: KLEIN SI MOLINO BF CZEKAJ M GARDNER CJ CHU V BROWN K SABATINO RD BOSTWICK JS KASIEWSKI C BENTLEY R WINDISCH V PERRONE M DUNWIDDIE CT LEADLEY RJ
Citation: Si. Klein et al., DESIGN OF A NEW CLASS OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 41(14), 1998, pp. 2492-2502
CONSTRAINED BETA-ALANINE BASED GPIIB IIIA ANTAGONISTS/
Authors: KLEIN SI CZEKAJ M MOLINO BF CHU V
Citation: Si. Klein et al., CONSTRAINED BETA-ALANINE BASED GPIIB IIIA ANTAGONISTS/, Bioorganic & medicinal chemistry letters, 7(13), 1997, pp. 1773-1778
CONFORMATIONALLY FLEXIBLE PLATELET-AGGREGATION INHIBITORS BASED ON THE TETRAPEPTIDE ARG-GLY-ASP-ARG
Authors: KLEIN SI CZEKAJ M MOLINO BF CHU V
Citation: Si. Klein et al., CONFORMATIONALLY FLEXIBLE PLATELET-AGGREGATION INHIBITORS BASED ON THE TETRAPEPTIDE ARG-GLY-ASP-ARG, European journal of medicinal chemistry, 32(10), 1997, pp. 833-839
IN-VITRO CHARACTERIZATION OF A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST RPR-109891 AND ITS ACTIVE METABOLITE RPR-109039
Authors: CHU V SABATINO R BROWN K KLEIN S CZEKAJ M GARDNER C LEADLEY R BOSTWICK J KASIEWSKI C OCONNOR E PERRONE M DUNWIDDIE C
Citation: V. Chu et al., IN-VITRO CHARACTERIZATION OF A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST RPR-109891 AND ITS ACTIVE METABOLITE RPR-109039, Blood, 90(10), 1997, pp. 3214-3214
NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS BASED UPON A 4-SUBSTITUTEDPIPERIDINE SCAFFOLD
Authors: KLEIN SI MOLINO BF CZEKAJ M DENER JS LEADLEY RJ SABATINO R DUNWIDDIE CT CHU V
Citation: Si. Klein et al., NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS BASED UPON A 4-SUBSTITUTEDPIPERIDINE SCAFFOLD, Bioorganic & medicinal chemistry letters, 6(12), 1996, pp. 1403-1408
IN-VIVO ANTITHROMBOTIC ACTIVITY OF RG13965, A NOVEL PLATELET FIBRINOGEN RECEPTOR ANTAGONIST
Authors: BOSTWICK J KASIEWSKI C CHU V SABATINO R KLEIN S CZEKAJ M GARDNER C PERRONE M DUNWIDDIE C COOK J LEADLEY R
Citation: J. Bostwick et al., IN-VIVO ANTITHROMBOTIC ACTIVITY OF RG13965, A NOVEL PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, The FASEB journal, 9(4), 1995, pp. 938-938
ANTITHROMBOTIC ACTIVITY OF RPR110173, AN ORALLY-ACTIVE PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, IN CANINE MODELS OF ARTERIAL THROMBOSIS
Authors: LEADLEY RJ BOSTWICK JS KASIEWSKI CJ CHU V KLEIN SI CZEKAJ M GARDNER CJ PERRONE MH DUNWIDDIE CT
Citation: Rj. Leadley et al., ANTITHROMBOTIC ACTIVITY OF RPR110173, AN ORALLY-ACTIVE PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, IN CANINE MODELS OF ARTERIAL THROMBOSIS, Circulation, 92(8), 1995, pp. 2329-2329
Risultati: 1-9 |